Russian version of the neurogenic bladder symptom score (NBSS)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. The Neurogenic Bladder Symptom Score (NBSS) is widely used now for the bladder symptoms assessment in neurogenic low urinary tract dysfunction. It is suitable for all patients, regardless of a bladder management method. NBSS contains 24 questions, which focus on incontinence, storage and voiding symptoms, urinary complications and life quality. With the permission of the authors (Dr.Welk et al.), NBSS had been translated into Russian according to the cultural and lingual adaptation algorithm. Objectives. Validate the Russian version of NBSS for multiple sclerosis patients. Design, setting, and participants. The study included 80respondents: group A - 40 multiple sclerosis (MS) patients with neurogenic bladder, group B - 40 multiple sclerosis (MS) patients without bladder dysfunction, group C - healthy controls. All participants filled out the NBSS two times with an interval of two weeks. They also completed other measurement tools (IPSS,OAB Awareness Tool, WHOQOL BREF).Data were used to determine the internal consistency (Cronbach’s alfa), external validity (Pearson correlation), and test-re-test reliability with interclass correlation coefficient. Results. The mean of the NBSS total in the group A was 22.56±12.6, which significantly (p<0.001) exceeded score in comparable groups B (6.42±2.3) and C (5.31±1.9). The Cronbach’s alfa of the total and the in continence, storage/voiding, and consequences domains was 0.939, 0,965, 0,801 and 0.712 respectively, which confirms the high internal consistency of the Russian version of the NBSS. External validity was verified by the relevant correlations with other questionnaires. Test-retest reliability was excellent. The interclass correlation coefficients were >0.85 (p<0.001) for all subdomains and the overall score. Conclusion. The Russian version of the NBSS demonstrated good validity and reliability and may be recommended for use in clinical practice.

Full Text

Restricted Access

About the authors

E. S Philippova

Sverdlovsk Regional Clinical Hospital; Ural State Medical University

Email: fiдippova.cat@yandex.ru
PhD, urologist; Associate professor

I. V Bazhenov

Ural State Medical University; Sverdlovsk Regional Clinical Hospital

Email: biv@okb1.ru
MD, Professor; Head of Urological center

L. I Volkova

Ural State Medical University; Sverdlovsk Regional Clinical Hospital

Email: vli@okb1.ru
MD, Professor, Head of neurological department

E. Y Moskvina

Sverdlovsk Regional Clinical Hospital; Ural State Medical University

Email: moskwina.cat@yandex.ru
neurologist; Assistant professor

E. L Turova

Sverdlovsk Regional Clinical Hospital

neurologist

Y. V Popova

Sverdlovsk Regional Clinical Hospital

Email: yuwa-11@mail.ru
neurologist

References

  1. Kalsi V., Fowler C.J. Therapy insight: bladder dysfunction associated with multiple sclerosis. Nat ClinPract Urol. 2005;2(10):492-501.
  2. Welk B., Morrow S.A., Madarasz W., Potter P., Sequeira K. The conceptualization and development of a patient-reported Neurogenic Bladder Symptom Score. Res Rep Urol. 2013;5:129-137.
  3. Welk B., Morrow S., Madarasz W., Baverstock R., Macnab J., Sequeira K. The validity andreliability of the Neurogenic Bladder Symptom Score. J Urol. 2014;192:452-457.
  4. Welk B., Lenherr S., Elliot S., Stoffel J., Presson A.P., Zhang C., Myers J.B. The Neurogenic Bladder Symptom Score (NBSS): a secondary assessment of its validity, reliability among people with spinal cord injury. Spinal Cord. 2018;56(3):259-264.
  5. Welk B., Carlson K., Baverstock R A pilot study of the responsiveness of the Neurogenic Bladder Symptom Score (NBSS). Can Urol Assos J. 2017;11(12):376-378.
  6. Fragalà E., Russo G.I., Di Rosa A., Giardina R., Privitera S., Favilla V., Patti F., Welk B., Cimino S., Castelli T., Morgia G. Association between the Neurogenic Bladder Symptom Score and urodynamic examination in Multiole Sclerosis patients with lower urinary tract dysfunction. Int Neurourol J. 2015;19;272-277.
  7. Clark R., Welk B. Patient reported outcome measures in neurogenic bladder. Transl Androl Urol. 2016;5(1):22-30.
  8. Costa P., Perrouin-Verbe B., Colvez A., Didier J., Marquis P., Marrel A., Amarenco G., Espirac B., Leriche A. Quality oflife in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Eur Urol. 2001;39:107-113.
  9. Bonniaud V., Bryant D., Parratte B., Guyatt G. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol. 2008;180:2592-2598.
  10. Patrick D.L., Martin M.L., Bushnell D.M., Yalcin I., Wagner T.H., Buesching D.P. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology. 1999;53:71-76.
  11. Schurch B., Denys P., Kozma C.M., Reese P.R., Slaton T., Barron R. Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence. ArchPhys Med Rehabil 2007;88:646-652.
  12. Bates D., Burks J., Globe D., Signori M., Hudgens S., Denys P., Macdiarmid S., Nitti V., Odderson I., Ross A.P., Chancellor M. Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurol. 2013;13:78.
  13. Patel D.P., Elliott S.P., Stoffel J.T., Brant W.O., Hotaling J.M., Myers J.B. Patient reportedoutcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. Neurourol Urodyn 2016;35:8-14.
  14. Kalpakjian C.Z., Scelza W.M., Forchheimer M.B. et al. Preliminary reliability and validity of a Spinal Cord Injury Secondary Conditions Scale. J Spinal Cord Med. 2007;30:131-139.
  15. Tulsky D.S., Kisala P.A., Tate D.G., Spungen A.M., Kirshblum S.C. Development and psychometric characteristics of the SCI-QOL Bladder Management Difficulties and Bowel Management Difficulties item banks and short forms and the SCIQOLSCIQOL Bladder Complications scale. J Spinal Cord Med. 2015;38:288-302.
  16. Jette A.M., Tulsky D.S., Ni P., Kisala P.A., Slavin M.D., Dijkers M.P., Heinemann A.W., Tate D.G., Whiteneck G., Charlifue S., Houlihan B., Williams S., Kirshblum S., Dyson-Hudson T., Zanca J., Fyffe D. Development and initial evaluation of the spinal cord injury-functional index. Arch Phys Med Rehabil. 2012;93:1733-1750.
  17. Vickrey B.G., Hays R.D., Harooni R et al. Hays R.D., Harooni R., Myers L.W., Ellison G.W. Qual Life Res1995;4:187-206.
  18. Hobart J., Lamping D., Fitzpatrick R., Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001;124:962-973.
  19. Cella D.F., Dineen K., Arnason B., Reder A., Webster K.A., karabatsos G., Chang C., Lloyd S., Steward J., Stefoski D. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology. 1996;47:129-139.
  20. Gold S.M., Heesen C., Schulz H., Guder U., Mönch A., Gbadamosi J., Buhmann C., Schulz K.H. Disease specific quality of life instruments in multiple sclerosis: validation ofthe Hamburg Quality ofLife Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler. 2001;7:119-130.
  21. Marrie R.A., Miller D.M., Chelune G.J., Cohen J.A. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler. 2003;9:621-626.
  22. Parkin P.C., Kirpalani H.M., Rosenbaum P.L., Fehlings D.L., Van Nie A., Willan A.R., King D. Development of a health-related quality of life instrument for use in children with spina bifida. Qual Life Res. 1997;6:123-132.
  23. Moore K.N., Jensen L. Testing of the Incontinence Impact Questionnaire (IIQ-7) with men after radical prostatectomy. J Wound Ostomy Continence Nurs. 2000;27:304-312.
  24. Okamura K., Nojiri Y., Osuga Y. Reliability and validity of the King’s Health Questionnaire for lower urinary tract symptoms in both genders. BJU Int. 2009;103:1673-1678.
  25. Coyne K., Revicki D., Hunt T., Corey R., Stewart W., Bentkover J., Kurth H., Abrams P. Psychometric validation of an overactive bladder symptom and health related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11:563-574.
  26. Barry M.J., Fowler F.J. Jr, O’Leary M.P., Bruskewitz R.C., Holtgrewe H.L., Mebust W.K., Cockett A.T. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549-1557. discussion 1564.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies